Search Close Search
Search Close Search
Page Menu

News

Getting Results…
  • Cole Haynes receives investigator award from HHMI, Gates & Simons foundations

    Cole Haynes receives investigator award from HHMI, Gates & Simons foundations

    Cole Haynes, PhD, was named one of 84 faculty scholars by the Howard Hughes Medical Institute (HHMI), the Simons Foundation, and the Bill & Melinda Gates Foundation.

    Read more
  • Craig Peterson receives $4.5 million outstanding investigator award from NIH

    Craig Peterson receives $4.5 million outstanding investigator award from NIH

    UMass Medical School scientist Craig L. Peterson, PhD, has received a five-year, $4.5 million Maximizing Investigators' Research Award (MIRA) from the National Institutes of Health for research that explores the role chromosome structure plays in regulating gene expression, DNA repair and DNA fidelity during cell division.

    Read more
  • PhD candidate Yvonne Chan a ‘protein engineer’

    PhD candidate Yvonne Chan a ‘protein engineer’

    In this Women in Science video, PhD candidate Yvonne Chan talks about her exploration of how proteins fold and maintain their three-dimensional structure.

    Read more
  • Dohoon Kim receives $2 million Young Investigator Award from Suh Kyungbae Science Foundation

    Dohoon Kim receives $2 million Young Investigator Award from Suh Kyungbae Science Foundation

    Dohoon Kim, PhD, was named a 2017 Suh Kyungbae Science Foundation Young Investigator Award recipient. The accompanying $2 million, five-year grant will support research into changes in metabolic pathways that support cancer cells.

    Read more
  • Four faculty members appointed to endowed professorships

    Four faculty members appointed to endowed professorships

    Four faculty members have been appointed to endowed professorships at UMass Medical School in recognition of their contributions to biomedical research, education and patient care. Each will be formally invested Sept. 13 at the Convocation and Investiture ceremony.

    Read more
  • FDA approves first drug to use RNA interference, based on discoveries made at UMass Medical School

    FDA approves first drug to use RNA interference, based on discoveries made at UMass Medical School

    The new drug, patisiran, approved Aug. 10 by the FDA, is based on the discovery of RNAi made by Craig Mello, PhD, and Andrew Fire, PhD. It was developed by Alnylam, an RNAi-based drug development company co-founded by Phillip Zamore, PhD.

    Read more
  • New genome-editing strategy developed at UMMS may lead to therapeutics

    New genome-editing strategy developed at UMMS may lead to therapeutics

    Researchers at UMass Medical School have developed a genome-editing strategy to correct disease-causing DNA mutations in mouse models of human genetic diseases. Dan Wang, PhD, is first author and Guangping Gao, PhD, is a co-corresponding author on the paper published in the Aug. 18 edition of Nature Biotechnology.

    Read more
  • Raziel Rojas-Rodriguez studies adipose tissue function in metabolism during pregnancy

    Raziel Rojas-Rodriguez studies adipose tissue function in metabolism during pregnancy

    Raziel Rojas-Rodriguez, a PhD candidate in the Program in Molecular Medicine, is studying how adipose tissue expansion during pregnancy is related to metabolic health. Learn more about her research in this Women in Science video. 

    Read more
  • Guangping Gao named a top translational scientist by Nature Biotechnology

    Guangping Gao named a top translational scientist by Nature Biotechnology

    Guangping Gao, PhD, has been ranked one of the world’s top translational researchers, according to a new tabulation from Nature Biotechnology. The Top 20 Translational Researchers of 2017, published this month by Nature Biotechnology, places Dr. Gao fourth.

    Read more
  • Job Dekker and colleagues develop new model to examine large mutations in cells

    Job Dekker and colleagues develop new model to examine large mutations in cells

    Job Dekker, PhD, creator of high-throughput chromosome conformation capture (known as Hi-C), and a team of researchers have developed a new computational framework combining optical mapping, Hi-C, and whole genome sequencing to find what are called “structural variants” within cancer genomes and learn more about how such cancers begin.

    Read more
Showing 1-10 of 100 items
of 10